125 related articles for article (PubMed ID: 8186888)
1. Polymerase chain reaction-single strand conformation polymorphism analysis of the p53 gene in paraffin-embedded surgical material from human renal cell carcinomas.
Kikuchi Y; Kishi T; Suzuki M; Furusato M; Aizawa S
Virchows Arch; 1994; 424(3):229-33. PubMed ID: 8186888
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
[TBL] [Abstract][Full Text] [Related]
3. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
[TBL] [Abstract][Full Text] [Related]
4. p53 gene mutation in primary human renal cell carcinoma.
Torigoe S; Shuin T; Kubota Y; Horikoshi T; Danenberg K; Danenberg PV
Oncol Res; 1992; 4(11-12):467-72. PubMed ID: 1299377
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
Oda H; Nakatsuru Y; Ishikawa T
Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636
[TBL] [Abstract][Full Text] [Related]
6. Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors.
Chemeris G; Loktinov A; Rempel A; Schwarz M; Bannasch P
Virchows Arch; 1995; 426(6):563-9. PubMed ID: 7655736
[TBL] [Abstract][Full Text] [Related]
7. Infrequent mutation of p53 gene in human renal cell carcinoma detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Suzuki Y; Tamura G; Satodate R; Fujioka T
Jpn J Cancer Res; 1992 Mar; 83(3):233-5. PubMed ID: 1582882
[TBL] [Abstract][Full Text] [Related]
8. Absence of ras mutations and low incidence of p53 mutations in renal cell carcinomas induced by ferric nitrilotriacetate.
Akiyama T; Hamazaki S; Okada S
Jpn J Cancer Res; 1995 Dec; 86(12):1143-9. PubMed ID: 8636002
[TBL] [Abstract][Full Text] [Related]
9. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
Zhuang Z; Gnarra JR; Dudley CF; Zbar B; Linehan WM; Lubensky IA
Mod Pathol; 1996 Aug; 9(8):838-42. PubMed ID: 8871925
[TBL] [Abstract][Full Text] [Related]
10. Detection of p53 gene alteration in renal-cell cancer by micropreparation techniques of tumor specimens.
Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Arndt H; Paeslack U; Werner M; Tan HK; Jonas U
Int J Cancer; 1995 Dec; 64(6):399-406. PubMed ID: 8550242
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
12. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
13. Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.
Wu WJ; Kakehi Y; Habuchi T; Kinoshita H; Ogawa O; Terachi T; Huang CH; Chiang CP; Yoshida O
Jpn J Cancer Res; 1995 Aug; 86(8):730-6. PubMed ID: 7559095
[TBL] [Abstract][Full Text] [Related]
14. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
[TBL] [Abstract][Full Text] [Related]
15. Retinoblastoma gene mutation in primary human renal cell carcinoma.
Shuin T; Torigoe S; Kubota Y; Kishida T; Hosaka M; Horikoshi T; Yao M; Kondo K; Sakai N; Danenberg K
Oncol Res; 1995; 7(2):63-6. PubMed ID: 7579728
[TBL] [Abstract][Full Text] [Related]
16. Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction.
Oka K; Ishikawa J; Bruner JM; Takahashi R; Saya H
Mol Carcinog; 1991; 4(1):10-3. PubMed ID: 2009130
[TBL] [Abstract][Full Text] [Related]
17. p53 mutations and MDM-2 amplification in renal cell cancers.
Imai Y; Strohmeyer TG; Fleischhacker M; Slamon DJ; Koeffler HP
Mod Pathol; 1994 Sep; 7(7):766-70. PubMed ID: 7824511
[TBL] [Abstract][Full Text] [Related]
18. The 72nd codon change of p53 in primary renal cell carcinoma was confirmed as a polymorphism among Japanese.
Kageyama Y; Yamamura Y; Oshima H; Ikawa Y
Eur Urol; 1997; 31(1):81-5. PubMed ID: 9032540
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the p53 gene in carcinomas of the urinary system.
Suzuki Y; Tamura G
Acta Pathol Jpn; 1993 Dec; 43(12):745-50. PubMed ID: 8109252
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
